RxDoctor Payments Data

Iani Patsias, MD

Cardiovascular Disease · Hollywood, FLNPI 1710253331

Payments from drug & device makers

$25,326in general payments, 2019–2025

Across 24 payments — averaging $1055.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Prolaio, Inc.$18K
  • Abbott$7K
  • Philips North America LLC$38
  • Bayer$18
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$8

What the payments were for

  • Consulting fees$80048%
  • Travel & lodging$342%
  • Food & beverage$61937%
  • Education$21313%

General payments by program year

19
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Prolaio, Inc.6$18,075
Abbott15$7,187
Philips North America LLC1$38
Bayer1$18
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)1$8

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$25,326 in reported general payments places this provider in the 80th percentile of 1,740 cardiovascular disease providers in Florida.

See all cardiovascular disease providers in Florida

Medicare billing

Part B allowed, 2024
$56,103
Medicare patients
199
Services billed
547

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VyndamaxTafamidis95$2,100,149
UptraviSelexipag44$1,135,120
OpsumitMacitentan39$508,687
EntrestoSacubitril/Valsartan257$278,098
Tyvaso DpiTreprostinil12$270,540
FarxigaDapagliflozin Propanediol255$245,218
VyndaqelTafamidis Meglumine11$231,531
CamzyosMavacamten27$217,903
Orenitram ErTreprostinil Diolamine30$162,827
JardianceEmpagliflozin109$100,267
EliquisApixaban108$89,892
Ambrisentan12$34,200
XareltoRivaroxaban41$27,870
OzempicSemaglutide33$27,868
VerquvoVericiguat14$19,052

Paid to pharmacies, not to this prescriber.

Other cardiovascular disease in Hollywood

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →